pharmaceuticals
More News
-
India orders new drug-making standards after overseas deaths
Indian pharmaceutical firms face new standards amid safety concerns; small companies request deadline extensions
-
India firm denies tampering with tests in probe of cough syrup deaths
Pharmaceutical company Maiden denies tampering with cough syrup samples linked to child deaths in Gambia
-
Pharma Bureau urges govt action amid drug shortages
Executive director says grey market has become bigger than white market
-
India becoming the hub of narcos
India’s chemical and pharmaceutical industry under the radar because of its weak regulatory and legislative regimes
-
K-P inspectors find 610 medicines substandard
375 medical stores were sealed last year, FIRs lodged against 35 individuals
-
DRAP urges govt to trade in yuan
Warns that pharmaceutical production in the country will come to a halt
-
Medicines worth Rs160 million donated to Afghanistan
Three trucks carrying 2,000 food packs handed over to Afghan officials
-
DRAP revises fee for various licences, other facilities
Rs22,500 set as fee for renewal of drug manufacturing licences
-
Sindh minister slams Centre for allowing rise in medicine prices
Federal govt considers itself helpless before pharmaceuticals, says Dr Pechuho
-
Drug prices
Will the govt risk letting pharma companies go rogue?
-
Government unveils plan to stabilise medicine prices
Dr Zafar Mirza says govt to present new policy; revamp hospitals in Islamabad
-
DRAP suspends production of 143 overpriced medicines
31 manufacturers suspended in crackdown on unauthorised increase
-
Pharmaceuticals: ‘Punjab contributes 60% to industry’
Some of the big hurdles in promoting the industry are the previous government’s amendments to the Drug Act 1976
-
Dangerous drug inspectors
Pharmaceuticals — drugs for prescription primarily — are big business
-
Samsung's bio-drug unit to raise $2 bn in upcoming IPO
The firm makes biopharmaceutical drugs for major firms including Bristol-Myers Squibb and Roche
-
Consolidation or domination?
It will be interesting to see how Europe will respond to the world’s biggest GMO seller becoming a European company
-
Lies and medicine
Pharmaceutical companies have once again started a campaign to push for an increase in the price of common medicines
-
Substandard and spurious: PPMA dismayed at decision to bracket the two
Association laments government’s policy to put drugs in same category.